⌘K

Login Start Free

Home/Filings/4/0001121781-15-000197

4//SEC Filing

GUIDED THERAPEUTICS INC 4

Accession 0001121781-15-000197

$GTHPCIK 0000924515operating

View on SEC.gov Company Profile

Filed

Jul 16, 8:00 PM ET

Accepted

Jul 17, 5:06 PM ET

Size

23.8 KB

Accession

0001121781-15-000197

Insider Transaction Report

Form 4

Period: 2015-05-29

GUIDED THERAPEUTICS INCGTHP

Director10% Owner

Transactions

Award
Options
2015-05-29+600,000→ 600,000 total
Exercise: $0.10From: 2015-05-29Exp: 2025-05-28→ Common Stock (600,000 underlying)
Sale
Tranche B Warrants
2015-06-19−3,797,789→ 0 total
Exercise: $0.10From: 2013-05-22Exp: 2018-05-22→ Common Stock (3,797,789 underlying)
Sale
Warrants
2015-06-30−58,935→ 0 total
Exercise: $0.23From: 2014-12-02Exp: 2019-12-02→ Common Stock (58,935 underlying)
Award
Common Stock
2015-06-30+113,636→ 9,885,973 total
Sale
Tranche A Warrants
2015-06-19−367,647→ 0 total
Exercise: $1.08From: 2013-05-22Exp: 2018-05-22→ Common Stock (367,647 underlying)
Purchase
Common Stock
2015-06-29+18,752→ 9,904,725 total
Purchase
Tranche A Warrants
2015-06-19+367,647→ 367,647 total
Exercise: $0.10From: 2013-05-22Exp: 2018-05-22→ Common Stock (367,647 underlying)
Purchase
Warrants
2015-06-30+58,935→ 58,935 total
Exercise: $0.11From: 2015-12-02Exp: 2020-12-02→ Common Stock (58,935 underlying)
Purchase
Tranche B Warrants
2015-06-19+3,797,789→ 3,797,789 total
Exercise: $0.09From: 2013-05-22Exp: 2018-05-22→ Common Stock (3,797,789 underlying)
Purchase
Warrants
2015-06-30+58,935→ 58,935 total
Exercise: $0.09From: 2015-12-02Exp: 2020-12-02→ Common Stock (58,938 underlying)

Footnotes (4)

[F1]On June 30, 2015, the reporting person disposed of warrants to purchase common stock in exchange for new warrants to purchase common stock and shares of common stock in an exchange with the issuer.
[F2]These shares were granted as dividend on the issuer's Series B preferred stock.
[F3]These options to purchase common stock were granted under the Guided Therapeutics, Inc. 1995 Stock Plan as amended; as 2015 director's fees, in lieu of cash. The options are 100% vested.
[F4]On June 19, 2015, the reporting person disposed of warrants to purchase common stock in exchange for new warrants to purchase common stock in an exchange with the issuer.

Documents

1 file

4
jeifm471715.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

GUIDED THERAPEUTICS INC

CIK 0000924515

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000924515

Filing Metadata

Form type: 4
Filed: Jul 16, 8:00 PM ET
Accepted: Jul 17, 5:06 PM ET
Size: 23.8 KB

View on SEC.gov